Physician Assistant in Delano, CA Accepting Medicare

9 Physician Assistant nurses found. Showing 1 - 9

Mr. Daniel W Jordan, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: 325 S Lexington St, Delano, CA 93215 Phone: 661-725-6266    Fax: 661-725-0407

Duyen Ky Tran, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 425 Del Sol Pkwy, Delano, CA 93215 Phone: 661-720-4011    Fax: 661-720-4012

Mr. Chung Kay Li, P.A.; RPT Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 1004 14th Ave, Delano, CA 93215 Phone: 661-474-2600    Fax: 661-474-2600

Derek Allan Harmon, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1508 Garces Hwy # 1, Delano, CA 93215 Phone: 661-725-4780    Fax: 661-869-1503

Courtney Nicole Grayson, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1401 Garces Hwy, Delano, CA 93215 Phone: 661-725-4800

Mr. Jeffrey Sangwon Cho, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1401 Garces Hwy, Delano, CA 93215 Phone: 661-725-4800

Lamin T Seisay, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1401 Garces Hwy, Delano, CA 93215 Phone: 661-721-5262

Mr. John Arvizu Nunez, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1230 Jefferson St, Delano, CA 93215 Phone: 661-725-7793    Fax: 661-725-0595

Aisha Sheikh, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: 1401 Garces Highway, Delano, CA 93215 Phone: 661-725-4800

News Archive

Pfizer and Nektar resolve outstanding Exubera contractual issues

Pfizer and Nektar Therapeutics have announced that the two companies have resolved all outstanding contractual issues in connection with Exubera and Nektar's innovative Next Generation Inhaled Insulin (NGI) product currently in Phase 1 clinical development.

HHS secretary Sebelius testifies before Senate appropriations panel

During her testimony, the Health and Human Services secretary took questions on the health law and pointed out — according to Modern Healthcare — funding concerns related to rural critical access hospitals and anti-fraud and abuse efforts.

FDA approves CSL Behring's Hizentra for PI

CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for HizentraTM, Immune Globulin Subcutaneous (Human), 20% Liquid, for treating patients diagnosed with primary immunodeficiency (PI). A once weekly immunoglobulin (Ig) replacement therapy, Hizentra provides effective protection against infection by maintaining a steady and normal level of immunoglobulin in the body.

Viral protein could be a major player in SARS virulence

Ever since the previously unknown SARS virus emerged from southern China in 2003, University of Texas Medical Branch at Galveston virologists have focused on finding the source of the pathogen's virulence - its ability to cause disease. In the 2003 epidemic, for example, between 5 and 10 percent of those who fell sick from the SARS virus died, adding up to more than 900 fatalities worldwide.

Read more Medical News

› Verified 9 days ago